CD40 Ligand Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
Table of Content
1 Industrial Chain Overview
- 1.1 CD40 Ligand Industry
- 1.1.1 Overview
- 1.1.2 Characteristics of CD40 Ligand
- 1.2 Upstream
- 1.2.1 Major Materials
- 1.2.2 Manufacturing Overview
- 1.3 Product List By Type
- 1.3.1 ISF-35
- 1.3.2 LOAd-700
- 1.3.3 MEDI-4920
- 1.3.4 MegaCD40L
- 1.3.5 Others
- 1.4 End-Use List
- 1.4.1 Demand in Hepatitis B
- 1.4.2 Demand in Bladder Cancer
- 1.4.3 Demand in Liver Cancer
- 1.4.4 Demand in Ovarian Cancer
- 1.4.5 Demand in Others
- 1.5 Global Market Overview
- 1.5.1 Global Market Size and Forecast, 2015-2025
- 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
- 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
- 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 Global Production & Consumption by Geography
- 2.1 Global Production & Consumption
- 2.1.1 Global Production
- 2.1.2 Global Consumption
- 2.2 Geographic Production & Consumption
- 2.2.1 Production
- 2.2.1.1 Asia-Pacific
- 2.2.1.2 North America
- 2.2.1.3 South America
- 2.2.1.4 Europe
- 2.2.1.5 Middle East & Africa
- 2.2.2 Consumption
- 2.2.2.1 Asia-Pacific
- 2.2.2.2 North America
- 2.2.2.3 South America
- 2.2.2.4 Europe
- 2.2.2.5 Middle East & Africa
3 Major Manufacturers Introduction
- 3.1 Manufacturers Overview
- 3.2 Manufacturers List
- 3.2.1 Biogen, Inc. Overview
- 3.2.1.1 Product Specifications
- 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.1.3 Recent Developments
- 3.2.1.4 Future Strategic Planning
- 3.2.2 Bristol-Myers Squibb Company Overview
- 3.2.2.1 Product Specifications
- 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.2.3 Recent Developments
- 3.2.2.4 Future Strategic Planning
- 3.2.3 eTheRNA Immunotherapies NV Overview
- 3.2.3.1 Product Specifications
- 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.3.3 Recent Developments
- 3.2.3.4 Future Strategic Planning
- 3.2.4 ImmuNext, Inc. Overview
- 3.2.4.1 Product Specifications
- 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.4.3 Recent Developments
- 3.2.4.4 Future Strategic Planning
- 3.2.5 Juno Therapeutics Inc. Overview
- 3.2.5.1 Product Specifications
- 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.5.3 Recent Developments
- 3.2.5.4 Future Strategic Planning
- 3.2.6 MedImmune, LLC Overview
- 3.2.6.1 Product Specifications
- 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.6.3 Recent Developments
- 3.2.6.4 Future Strategic Planning
- 3.2.7 Targovax AS Overview
- 3.2.7.1 Product Specifications
- 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.7.3 Recent Developments
- 3.2.7.4 Future Strategic Planning
- 3.2.8 XL-protein GmbH Overview
- 3.2.8.1 Product Specifications
- 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
- 3.2.8.3 Recent Developments
- 3.2.8.4 Future Strategic Planning
4 Market Competition Pattern
- 4.1 Market Size and Sketch
- 4.2 Company Market Share
- 4.2.1 Global Production by Major Manufacturers
- 4.2.2 Market Concentration Analysis
- 4.3 Market News and Trend
- 4.3.1 Merger & Acquisition
- 4.3.2 New Product Launch
5 Product Type Segment
- 5.1 Global Overview by Product Type Segment
- 5.2 Segment Subdivision by Product Type
- 5.2.1 Market in ISF-35
- 5.2.1.1 Market Size
- 5.2.1.2 Situation & Development
- 5.2.2 Market in LOAd-700
- 5.2.2.1 Market Size
- 5.2.2.2 Situation & Development
- 5.2.3 Market in MEDI-4920
- 5.2.3.1 Market Size
- 5.2.3.2 Situation & Development
- 5.2.4 Market in MegaCD40L
- 5.2.4.1 Market Size
- 5.2.4.2 Situation & Development
- 5.2.5 Market in Others
- 5.2.5.1 Market Size
- 5.2.5.2 Situation & Development
6 End-Use Segment
- 6.1 Global Overview by End-Use Segment
- 6.2 Segment Subdivision
- 6.2.1 Market in Hepatitis B
- 6.2.1.1 Market Size
- 6.2.1.2 Situation & Development
- 6.2.2 Market in Bladder Cancer
- 6.2.2.1 Market Size
- 6.2.2.2 Situation & Development
- 6.2.3 Market in Liver Cancer
- 6.2.3.1 Market Size
- 6.2.3.2 Situation & Development
- 6.2.4 Market in Ovarian Cancer
- 6.2.4.1 Market Size
- 6.2.4.2 Situation & Development
- 6.2.5 Market in Others
- 6.2.5.1 Market Size
- 6.2.5.2 Situation & Development
7 Market Forecast & Trend
- 7.1 Regional Forecast
- 7.2 Consumption Forecast
- 7.2.1 Product Type Forecast
- 7.2.2 End-Use Forecast
- 7.3 Investment Trend
- 7.4 Consumption Trend
8 Price & Channel
- 8.1 Price and Cost
- 8.1.1 Price
- 8.1.2 Cost
- 8.2 Channel Segment
9 Market Drivers & Investment Environment
- 9.1 Market Drivers
- 9.2 Investment Environment
10 Research Conclusion
List of Tables
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025
Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025
Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025
Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume
Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD
Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume
Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD
Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD
Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume
Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD
Table Major Manufacturers Headquarters and Contact Information
Table Major Manufacturers Capacity List in 2018
Table Biogen, Inc. Overview List
Table CD40 Ligand Business Operation of Biogen, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table CD40 Ligand Business Operation of Bristol-Myers Squibb Company (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table eTheRNA Immunotherapies NV Overview List
Table CD40 Ligand Business Operation of eTheRNA Immunotherapies NV (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table ImmuNext, Inc. Overview List
Table CD40 Ligand Business Operation of ImmuNext, Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Juno Therapeutics Inc. Overview List
Table CD40 Ligand Business Operation of Juno Therapeutics Inc. (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table MedImmune, LLC Overview List
Table CD40 Ligand Business Operation of MedImmune, LLC (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Targovax AS Overview List
Table CD40 Ligand Business Operation of Targovax AS (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table XL-protein GmbH Overview List
Table CD40 Ligand Business Operation of XL-protein GmbH (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)
Table Global Production Volume List by Manufacturers, 2015-2018, in Volume
Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume
Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD
Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume
Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD
Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume
Table Global Market Forecast by Region Segment 2019-2025, in Million USD
Table Global Market Forecast by Region Segment 2019-2025, in Volume
Table Global Market Amount by Product Type Segment 2019-2025, in Million USD
Table Global Market Volume by Product Type Segment 2019-2025, in Volume
Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Table Global Market Volume by End-Use Segment 2019-2025, in Volume
List of Figures
Figure CD40 Ligand Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Volume and Growth Rate, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Volume and Growth Rate, 2015-2018, in Volume
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Volume Share by Manufacturers in 2019, in Volume
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in ISF-35, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in ISF-35, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in LOAd-700, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in LOAd-700, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in MEDI-4920, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in MEDI-4920, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in MegaCD40L, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in MegaCD40L, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Hepatitis B, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Hepatitis B, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Bladder Cancer, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Bladder Cancer, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Liver Cancer, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Liver Cancer, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Ovarian Cancer, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Ovarian Cancer, 2015-2018, in Volume
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume
- 6.2.1 Market in Hepatitis B
- 5.2.1 Market in ISF-35
- 3.2.1 Biogen, Inc. Overview
- 2.2.1 Production
According to 99Strategy, the Global CD40 Ligand Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global CD40 Ligand market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Biogen, Inc.
Bristol-Myers Squibb Company
eTheRNA Immunotherapies NV
ImmuNext, Inc.
Juno Therapeutics Inc.
MedImmune, LLC
Targovax AS
XL-protein GmbH
Key Product Type
ISF-35
LOAd-700
MEDI-4920
MegaCD40L
Others
Market by Application
Hepatitis B
Bladder Cancer
Liver Cancer
Ovarian Cancer
Others
Main Aspects covered in the Report
Overview of the CD40 Ligand market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development